News

The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus-eluting coronary stents for the additional indication to treat coronary chronic total occlusions (...

IVUS, CTOs

A new study found that intravascular ultrasound (IVUS)-guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided...

Medtronic Total Across Crossing Catheter CTO Peripheral Artery Disease PAD

Medtronic Inc. launched in Europe its Total across crossing catheter. Total received CE marking for improving blood...

Boston Scientific OffRoad Re-Entry Catheter System CTO PAD Cath Labs

Boston Scientific launched in the United States the OffRoad Re-Entry Catheter System to treat complete arterial...

OffRoad, CTO, OffRoad CTO Device, Boston Scientific

 The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the...

Enabler-C, EndoCross, enabler catheter

EndoCross, Ltd. announced today that it has already enrolled one-third of the patients planned for the first-in-human study of its Enabler-C Catheter System for Crossing Coronary Chronic Total...

balloon, CTO

Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires and balloon dilation catheters for...

Millennium Research Group Peripheral Vascular Device Market Growth

According to Millennium Research Group (MRG), increasing awareness and diagnosis of peripheral vascular disease (PVD) along with the introduction of improved next-generation devices will lead the...

Avinger Ocelot OCT CTO catheter

The U.S. Food and Drug Administration (FDA) has granted market clearance for the Avinger Inc. Ocelot optical coherenace tomography (OCT) catheter to help cross...

CONNECT II Clinical Trial CTO Crossing Catherter Peripheral Artery Disease

Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with...

BridgePoint Medical Boston Scientific CTO Crossing Catheters Cath Lab

September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a privately held company based in Minneapolis. BridgePoint Medical has developed...

Covidien Ltd Viance Crossing Catheter Enteer Re-entry System Cath Lab Catheters

Covidien announced the launch of the Viance Crossing Catheter and Enteer Re-entry System for treating chronic total occlusions (CTOs) endovascularly. The devices are now available in the United...

July 24, 2012 — Use of the retrograde approach to revascularizing coronary chronic total occlusions (CTOs) to deliver...

July 5, 2012 — Avinger Inc., a medical device manufacturer of multifunctional catheters, announced in June that it has successfully completed enrollment in its CONNECT II global clinical trial.

June 8, 2012 — Austin Heart announced its participation in CONNECT II, a global clinical trial that gives physicians access to a new imaging technology...

May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed...

Avinger Inc. announced the enrollment of the first European patient in the CONNECT II global clinical trial. The first patient was enrolled by Dr. Bernhard Reimers at Ospedale di Mirano in Mirano...

February 9, 2012 — Boston Scientific announced the United States launch of the TruePath CTO device, designed to facilitate the crossing of chronic total occlusions (CTOs, or complete blockages)...

January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology category.

January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the rights to its peripheral vascular products used to treat chronic total occlusions...